Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TP53 target 3 pseudogene (ENSG00000227910)
- Target
- ENSG00000227910
- Molecular classification
- Pseudogene
01
Overview
TP53 target 3 pseudogene is a non-functional DNA sequence in the human genome, displaying high homology to the tumor suppressor gene TP53 but incapable of producing a functional protein product[2][4]. It is annotated as a processed pseudogene: pseudogenes of this class are typically formed by the retrotransposition of TP53 mRNA, resulting in a gene-like but non-functional genomic fragment[2][4]. While most pseudogenes are presumed to be functionless, evidence is emerging that some may contribute to regulatory functions or genomic architecture, though such roles have not been established for TP53 target 3 pseudogene specifically[6]. Summary: The TP53 target 3 pseudogene is not a true therapeutic target and should not be considered in drug development or biological pathway analysis as a classical molecular entity. Its inclusion as "target" is incorrect for any context related to molecular pharmacology, receptor biology, or therapeutic intervention.
- Other names
- TP53 target 3 pseudogene
02
Mechanism of action
None
03
Biological functions
Generally, pseudogenes are non-functionalIn rare cases, pseudogenes may have regulatory roles, such as acting as molecular sponges for microRNAs, producing regulatory RNAs, or influencing chromatin architectureThere is no direct evidence for such functions in TP53 target 3 pseudogene
04
Disease associations
OtherPseudogenes can occasionally impact disease (e.g., complex disease associations by chromatin architecture or regulatory RNA)There is no specific association between TP53 target 3 pseudogene and any disease, including cancer, in current searchable literature
Beyond the preview
Go deeper on TP53 target 3 pseudogene (ENSG00000227910).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TP53 target 3 pseudogene (ENSG00000227910).